# Immix Biopharma, Inc.: Form 8-K, filed Jul 26, 2024

- Company: [Immix Biopharma, Inc.](/companies/immx.md) (CIK 1873835)
- Form: 8-K
- Filed: 2024-07-26
- Accepted by EDGAR: Jul 26, 2024, 09:30 ET
- Period: 2024-07-25
- Accession: 0001493152-24-029174
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1873835/000149315224029174/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1873835/000149315224029174/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1873835/000149315224029174/form8-k.htm

Filed Jul 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-029174. Last ingested by Listed: Nov 13, 2026, 15:56 ET. No prices; not investment advice.
